Fig 1: Effect of candidate splicing factor knockdown on sister chromatid cohesion. a Effect of splicing factor knockdown on nuclear phenotype in Hs578T cells 72 h after knockdown. Scale bar = 50 μm. b Percentage of cells displaying an abnormal nuclear phenotype 72 h after knockdown. Mean + stdev of at least 3 positions. c Percentage of p-Histone H3 positive cells upon splicing factor knockdown 72 h after knockdown. Nocodazole treatment was used as a positive control. Mean + stdev of 3 biological replicates. d Nuclear phenotype of p-histone H3 positive cells upon SNRPD2 knockdown in MDA-MB-231. Some cells with irregular nuclear phenotype are p-histone H3 positive (blue squares), while some are negative (white squares). Scale bar = 50 μm. e Overview of the factors involved in sister chromatid cohesion. Adapted from Peters et al, 2012. f Effect of SNRPD2, SNRPD3 and NHP2L1 knockdown on RNA expression levels of sororin, ESPL1, MAU2 and SMC1 in Hs578T 72 h after knockdown. Mean + stdev of 3 biological replicates. g Effect of SNRPD2, SNRPD3 and NHP2L1 knockdown on sororin, ESPL1, MAU2 and SMC1 expression levels 1, 2 and 3 days after knockdown in Hs578T. Mean + stdev of three biological replicates. (H) Protein MAU2, SMC1 and sororin levels 3 days after knockdown of SNRPD2, SNRPD3 and NHP2L1. Statistical significance was determined using ANOVA correcting for multiple testing. * p < 0.05, ** p < 0.01, *** p < 0.001
Fig 2: Knockdown of NHP2L1 and sensitivity to vincristine (VCR) and mitotic arrest in leukemic cell lines. Human leukemia cells infected with two different shRNAs against NHP2L1 show a decrease in NHP2L1 protein levels in CCRF‐CEM (a) and in NALM6 (c). After knockdown of NHP2L1, cells were treated for 72 h in the presence of increasing concentrations of VCR. VCR sensitivity (lethal concentration 50% [LC50]) Cell viability determined by MTT in CCRF‐CEM (b) and in NALM6 (d) are represented. Error bars represent SDs of three replicate experiments. Student’s t‐test was used to calculate p values. *p < 0.05, **p < 0.01. Human leukemia cells (CCRF‐CEM and NALM6) were infected with two different shRNAs (#1 and #2) against NHP2L1 and treated with vincristine for 24 h. Representative blots of phosphorylated Serine 10 in Histone H3 protein and of total Histone H3 after knockdown of NHP2L1 and 24‐h treatment with VCR were shown in CEM (e) and NALM6 cells (g). Phospho Histone H3 protein levels were quantified by densitometry, normalized to total Histone H3 signal and expressed in arbitrary units for the CEM cells (f) and for the NALM6 cells (h). Values are means ± SD of three independent experiments. Student’s t‐test was used to calculate p values. *p < 0.05, **p < 0.01
Fig 3: Candidate splicing factor knockdown results in sororin intron 1 retention leading to reduction of sororin protein levels. a Nuclear phenotype 72 h after candidate splicing factor or sororin knockdown in MDA-MB-231 and Hs578T cells. Scale bar = 50 μm. b Sororin intron 1 (i) and intron 2 (ii) retention 72 h after SNRPD2, SNRPD3 and NHP2L1 knockdown in Hs578T and MDA-MB-231 cells. Mean + stdev of 3 biological replicates. c Sororin intron 1 retention 72 h after knockdown of other splicing factor candidates in Hs578T and MDA-MB-231 cells. Mean + stdev of 3 biological replicates. d Confocal images of MDA-MB-231 cells 24 h after transfection with mScarlet, mScarlet tagged sororin (without introns) or mScarlet tagged sororin with intron 1 retained. mScarlet transfections were combined with GFP vectors to control for transfection efficiency. Scale bar = 100 μm. e Alternative splicing of sororin 24 h after transfection with different mScarlet-Sororin plasmids. Forward primer bound to mScarlet, reversed primer bound to sororin exon 2. f Sororin protein expression 24 h after co-transfection with mScarlet and GFP plasmids. Statistical significance was determined using ANOVA correcting for multiple testing. * p < 0.05, ** p < 0.01, *** p < 0.001
Fig 4: NHP2L1 expression and sensitivity of primary B leukemic cells to vincristine (VCR). NHP2L1 mRNA expression was determined by Affymetrix gene expression array. MTT was used to determine the sensitivity of primary cells to VCR. The association between log2 expression of NHP2L1 and VCR sensitivity was assessed in two cohorts of patients with acute lymphoblastic leukemia: (a) St. Jude Children’s Research Hospital and (b) Dutch Childhood Oncology Group (DCOG)/Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia (COALL) cohorts. Based on previously published criteria24 sensitive cells were defined as having a VCR concentration lethal to 50% of the cells (LC50) of 0.391 μg/ml (0.474 µM) or less, and resistant cells were defined as having an LC50 of 1.758 μg/ml (2.131 µM) or more. The horizontal line inside each box depicts the median, the upper and lower limits of the box are the 75th and 25th percentiles, respectively, and the vertical bars above and below each box indicate the maximum and minimum values, respectively. The p values were determined by linear regression comparing NHP2L1 gene expression and leukemia cell sensitivity to VCR
Fig 5: Effects of small molecule inhibitor of NHP2L1 U4 interaction on neurons and leukemic cells treated with vincristine (VCR). (a) VCR effects relative to dipyridamole (DIP) on neurons and two acute lymphoblastic leukemia (ALL) cell lines (CEM and NALM6). The y‐axis represents the ratio of the additive half‐maximal effective concentration (EC50) to the actual EC50 for the combination of VCR and DIP. Each bar represents a fixed concentration of DIP (0.25 µM [0.125 mg/L], 0.5 µM [0.25 mg/L], 1 µM [0.5 mg/L], 2.5 µM [1.265 mg/L], 5 µM [2.525 mg/L], and 10 µM [5.05 mg/L]). The whiskers are the 95% confidence interval of the measure. A ratio of one indicates the combination is additive, whereas a ratio greater or less than one indicates that the combination is either synergistic or antagonistic, respectively. (b) Representative images of human‐induced pluripotent stem cell (hiPSC) neurons (Peri.4 U) 72 h after treatment with increasing concentrations of VCR with or without increasing concentrations of DIP. Images were taken from the ImageXpress Micro imaging microscope at 10× magnification
Supplier Page from Abcam for Anti-NHP2L1 antibody